Current Pharmaceutical Biotechnology

58.8k citations
2.8k papers · indexed · active since 1950
Topics
RNA Interference and Gene DeliveryMonoclonal and Polyclonal Antibodies ResearchNanoparticle-Based Drug Delivery

In The Last Decade

Current Pharmaceutical Biotechnology

2.6k papers receiving 55.1k citations

Peers

Current Pharmaceutical Biotechnology
Comparison fields: 5 of 222
  • Molecular Biology 24.1k
  • Biomedical Engineering 5.4k
  • Oncology 4.7k
  • Immunology 4.3k
  • Radiology, Nuclear Medicine and Imaging 4.3k
Replace Annual Review of Medicine with:
Annual Review of Medicine United States
Expert Opinion on Investigational Drugs United States
Expert Opinion on Pharmacotherapy United States
Current Drug Targets United States
Frontiers in bioscience United States
Journal of Biomedical Science Taiwan
Trends in Molecular Medicine United States
Bioscience Reports China
Drug Design Development and Therapy China
Mediators of Inflammation China
Current Pharmaceutical Biotechnology relative to Annual Review of Medicine United States Annual Review of Medicine's profile →
Citations per field
00.5×1.5×
Annual Review of Medicine · 1×
Citations per year

Countries where authors publish in Current Pharmaceutical Biotechnology

Since Specialization
Citations

This map shows the geographic impact of research published in Current Pharmaceutical Biotechnology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Pharmaceutical Biotechnology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Pharmaceutical Biotechnology more than expected).

Fields of papers published in Current Pharmaceutical Biotechnology

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Pharmaceutical Biotechnology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Pharmaceutical Biotechnology.

About Current Pharmaceutical Biotechnology

The 2.8k papers published in Current Pharmaceutical Biotechnology in the last decades have received a total of 58.8k indexed citations . Papers published in Current Pharmaceutical Biotechnology usually cover Pharmaceutical Science (108 papers), Molecular Biology (1.1k papers) and Biotechnology (137 papers) specifically the topics of RNA Interference and Gene Delivery (149 papers), Monoclonal and Polyclonal Antibodies Research (125 papers) and Nanoparticle-Based Drug Delivery (103 papers). The most active scholars publishing in Current Pharmaceutical Biotechnology are Undurti N. Das, Prashant Bisen, David M. Dohan Ehrenfest, John S. Philo, Tsutomu Arakawa, Gabriele Bierbaum, Hans‐Georg Sahl, Janice M. Reichert, William C. Campbell and Αndroulla N. Miliotou.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2026